The tuberculosis (TB) program collaborates with health care professionals and local health agencies to prevent and manage the spread of TB in Wyoming. The program maintains patient assistance programs to help with the cost of diagnostic lab testing and medications for individuals with TB infection or disease. The program also oversees directly observed therapy for individuals with active TB and conducts contact testing for individuals with infectious TB.
If you are in need of a TB test, those tests can be performed by your health care provider or at a local public health nursing office. Please contact your provider or closest public health nursing office regarding TB testing.
TB Treatment Medical Records Request
To obtain TB Treatment records contact the medical provider who prescribed the TB treatment .
If the medical provider who prescribed the TB treatment is no longer in practice and you received treatment through WDH TB Program Patient Assistance Program complete the records request form according to the directions and in the Information Released FROM section check Public Health Division and in the Information to be Released section write TB treatment records. Email or fax the completed form and a clear copy of your proof of identity to cdu.treatment@wyo.gov or 307-777-5279. For questions contact the TB Controller, Sarah Hendricks, at 307-777-6563.
Healthcare Facilities and Healthcare Workers
2023 Guidance Long Term Care & Residential Facilities Guidance: This document from the WDH TB program is meant to be used as bare minimum guidance, not as a regulation or formal testing protocol. In Wyoming, regulation of healthcare entities falls under the jurisdiction of Wyoming Healthcare Licensing and Surveys (WY HLS). The WDH TB program encourages facilities to review internal (facility, company), state (WY HLS), and certification (such as JCAHO) policies related to TB testing of residents and follow the most stringent guidance. If none of these entities address TB testing of residents, the facility may establish one based their needs (i.e. apply CDC testing guidance for healthcare provider as to residents if your facility feels it is appropriate.)
Targeted Tuberculosis (TB) Screening Guidelines
Risk Assessment – Facility: Data is available on the CDU Surveillance Program and Statistics webpage. The WDH TB Program Facility Risk Assessment is a guide that provides a baseline recommendation for TB testing in a facility and is based on the type of facility and TB data. In Wyoming, regulation of healthcare entities falls under the jurisdiction of Wyoming Healthcare Licensing and Surveys (WY HLS). The WDH TB program encourages facilities to review internal (facility, company), state (WY HLS), and certification (such as JCAHO) policies related to TB testing of residents and follow the most stringent guidance.
TB Skin Test Not Indicated – Letter
Forms and Documents (English)
Tuberculosis (TB) Forms and Documents
Targeted Tuberculosis (TB) Screening Guidelines
TB Skin Test Not Indicated – Letter
Prior Authorization Request Form
Sputum Collection Instructions (English)
LATENT Treatment Completion/Discontinuation Letter
LATENT Directly Observed Therapy (DOT) Agreement
LATENT Treatment Patient Education
LATENT & ACTIVE Treatment Monitoring Form
LATENT & ACTIVE Patient Medication List
ACTIVE Contact Investigation Report
ACTIVE Contact Investigation Summary
ACTIVE Treatment Completion/Discontinuation Letter
ACTIVE Treatment Patient Education
ACTIVE Home Isolation Agreement
Forms and Documents (Spanish)
Evaluación de riesgo di tuberculosis del paciente (Patient TB Risk Assessment)
Sputum Collection Instruction (SPANISH)
Acuerdo de terapia observada directamente (Active TB DOT Agreement)
Acuerdo de aislamiento en el hogar (Home Isolation Agreement)
Tratamiento de la infección con tuberculosis (TB Infection Patient Education Form)
Tratamiento de la enfermedad de tuberculosis (TB Disease Patient Education Form)
Acuerdo de terapia de observación directa Infección tuberculosa latente (Latent TB DPT Agreement)
Confirmación de cumplimiento con el tratamiento (2021 LTBI Treatment Completion Confirmation Memo)
Corrections
Statistics
TUBERCULOSIS STATISTICS IN WYOMING
can now be found on the CDU Webpage under Surveillance Program and Statistics at https://health.wyo.gov/
TB Education And Training
Sputum Collection – Instructional Video 2
Sputum Collection Instructions (English)
Sputum Collection Instruction (SPANISH)
International Travel for U.S. Citizens
CDC Tuberculosis Information for International Travelers
TB 101
What is TB?
How is it spread
Latent vs Active and types of TB
Risk Factors
Symptoms
Diagnosis
Treatment
Isolation protocol
Prevention
Immigration
Electronic Disease Notification (EDN)
Interjurisdictional Notice (IJN)
Unaccompanied Minors
BCG Vaccination
Children
Childcare Workers
TB Case Management
Targeted Tuberculosis (TB) Screening Guidelines
Risk Assessment – Patient (English)
Risk Assessment – Patient (SPANISH)
TB Skin Test Not Indicated – Letter
Prior Authorization Request Form
LATENT Treatment Completion/Discontinuation Letter (English)
LATENT Directly Observed Therapy (DOT) Agreement (English)
Latent Directly Observed Therapy (DOT) Agreement (SPANISH)
LATENT Treatment Patient Education
LATENT & ACTIVE Treatment Monitoring Form
LATENT & ACTIVE Patient Medication List
ACTIVE Contact Investigation Report
ACTIVE Contact Investigation Summary
ACTIVE DOT Agreement (English)
ACTIVE DOT Agreement (SPANISH)
ACTIVE Treatment Completion/Discontinuation Letter
ACTIVE Treatment Patient Education (English)
ACTIVE Treatment Patient Education Form (SPANISH)
ACTIVE Home Isolation Agreement (English)
ACTIVE Home Isolation Agreement (SPANISH)